Millions of people are walking around with a cholesterol threat they know nothing about. A major analysis of data from over 20,000 patients reveals that elevated Lipoprotein(a), or Lp(a), dramatically increases the risk of stroke and cardiovascular death, even when standard cholesterol numbers look fine.
Lp(a) is a cholesterol-carrying particle that resembles LDL, the notorious "bad" cholesterol. But it comes with an extra protein that appears to make it far more dangerous to the heart and blood vessels. The treacherous part: about one in five people have elevated levels, yet most never know it because the condition produces no warning signs.
Researchers analyzed stored blood samples from participants in three major NIH clinical trials: ACCORD, PEACE, and SPRINT. All participants were age 40 or older. Using current medical standards to measure Lp(a) levels, scientists grouped patients by their readings and tracked cardiovascular outcomes over time.
The results, presented at the Society for Cardiovascular Angiography and Interventions conference in Montreal, show that high Lp(a) remains a powerful predictor of future heart problems regardless of whether someone already has heart disease. Even patients receiving standard treatment for cholesterol and other risk factors remained vulnerable if their Lp(a) was elevated.
The findings raise difficult questions about current approaches to heart disease prevention. Doctors have long known that Lp(a) matters, but questions lingered about how precisely it predicted risk in real patients, especially those without existing cardiac conditions. This new evidence suggests the threat is substantial and widespread.
Lp(a) is primarily inherited, meaning if your parents had high levels, you likely do too. That genetic component makes it a particularly insidious risk factor, since it cannot be simply controlled through diet or exercise alone the way other cholesterol types can be managed. For people with elevated Lp(a), researchers now suggest more aggressive management of all other heart disease risk factors may be necessary to offset the inherited danger.
The challenge for the medical community now is determining how to identify and treat millions of people carrying this invisible risk. Without symptoms and without routine screening for Lp(a), countless individuals remain unaware they need closer monitoring and possibly more intensive interventions to protect their hearts.
Author Jessica Williams: "This is the kind of inherited cardiac time bomb that deserves far more attention in routine checkups, because knowing you have it could literally save your life."
Comments